Publisher Correction: Efficacy and safety of praziquantel combined with artemisinin derivatives versus praziquantel monotherapy for schistosomiasis: a meta-analysis of randomized controlled trials.

This publisher correction addresses errors in a previously published meta-analysis comparing the efficacy and safety of praziquantel (PZQ) combined with artemisinin derivatives (ARTs) versus praziquantel monotherapy for schistosomiasis. The correction includes the addition of a missing figure (Figur...

Descripción completa

Detalles Bibliográficos
Publicado en:	Infection pp. 1 - 7
Autores principales:	Yang, Yao, Meng, Jiahao, Li, Chunhui, Liu, Pan, Wu, Yumei, Wang, Xuanyu, Xia, Zhuoyang, Gao, Shuguang
Formato:	Journal Article
Publicado:	Springer Nature Jun2026
Acceso en línea:	Ver este registro en EBSCOhost

Descripción
Sumario:	This publisher correction addresses errors in a previously published meta-analysis comparing the efficacy and safety of praziquantel (PZQ) combined with artemisinin derivatives (ARTs) versus praziquantel monotherapy for schistosomiasis. The correction includes the addition of a missing figure (Figure 2) related to the risk of bias assessment and the renumbering of Figures 3 through 8, which present meta-analytic findings on cure rates, egg count reduction, and adverse event incidence. The original article has been updated to reflect these corrections.